Transcriptomic predictors of rapid progression from mild cognitive impairment to Alzheimer's disease

Abstract Background Effective treatment for Alzheimer’s disease (AD) remains an unmet need. Thus, identifying patients with mild cognitive impairment (MCI) who are at high-risk of progressing to AD is crucial for early intervention. Methods Blood-based transcriptomics analyses were performed using a...

Full description

Saved in:
Bibliographic Details
Main Authors: Yi-Long Huang, Tsung-Hsien Tsai, Zhao-Qing Shen, Yun-Hsuan Chan, Chih-Wei Tu, Chien-Yi Tung, Pei-Ning Wang, Ting-Fen Tsai
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Alzheimer’s Research & Therapy
Subjects:
Online Access:https://doi.org/10.1186/s13195-024-01651-0
Tags: Add Tag
No Tags, Be the first to tag this record!